Three separate injectable medicines were recalled on a single day in late July, and one of them is a chemotherapy drug that manufacturers found to contain steel particles.
Sunny Pharmtech, based in Taoyuan City, Taiwan, announced a nationwide voluntary recall on July 24 of three lots of Cyclophosphamide for Injection, USP, in 1 gram and 2 gram vials, after particulate matter identified as steel was found in the product. The recall was conducted at the user level, meaning hospitals, clinics, and pharmacies rather than individual consumers.
